Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel × Genitourinary × 30 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 306 Urinary Bladder Neoplasms 93 Carcinoma, Renal Cell 93 Carcinoma, Transitional Cell 46 Neoplasms 44 Breast Neoplasms 41 Kidney Neoplasms 39 Ovarian Neoplasms 37 Colorectal Neoplasms 30 Carcinoma, Non-Small-Cell Lung 30 Melanoma 25 Endometrial Neoplasms 24 Non-Muscle Invasive Bladder Neoplasms 22 Neoplasm Metastasis 22 Lung Neoplasms 22 Pancreatic Neoplasms 21 Uterine Cervical Neoplasms 17 Stomach Neoplasms 14 Sarcoma 14 Esophageal Neoplasms 14 Adenocarcinoma 13 Triple Negative Breast Neoplasms 12 Prostatic Neoplasms, Castration-Resistant 12 Squamous Cell Carcinoma of Head and Neck 10 Carcinoma, Hepatocellular 10 Urethral Neoplasms 9 Head and Neck Neoplasms 9 Clear-cell metastatic renal cell carcinoma 9 Urologic Neoplasms 8 Testicular Neoplasms 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡